Results 51 to 60 of about 93,748 (310)
Clinical and Experimental Hypertension, 2020 The number of patients with heart failure (HF) is rapidly increasing. Although hypertension is related to onset of HF, antihypertensive treatment status for these patients has not been fully examined.
Mitsuru Ohishi +4 more
doaj +1 more source
British Journal of Clinical Pharmacology, EarlyView.SGLT2 inhibitors and GLP‐1 receptor agonists modestly lower blood pressure across diverse patient populations, including those without diabetes. These effects appear largely independent of glycaemic control and offer additive value in high‐risk patients with overlapping comorbidities.
Andrej Belančić +7 more
wiley +1 more source
Hepatology, EarlyView., 2022 Abstract Background and Aims Reliable noninvasive biomarkers are an unmet clinical need for the diagnosis of NASH. This study investigates the diagnostic accuracy of the circulating triggering receptor expressed on myeloid cells 2 (plasma TREM2) as a biomarker for NASH in patients with NAFLD and elevated liver stiffness.
Vineesh Indira Chandran +17 more
wiley +1 more source
Choosing antihypertensive treatment for a South African population
South African Family Practice, 2007 There is no uniform agreement as to which antihypertensive drugs should be given for initial therapy. All of the antihypertensive agents are roughly equally effective, producing a good antihypertensive response in 30 to 50 percent of cases.
M.T. Mpe
doaj +1 more source
Advances in Pharmacological Insights of Borago officinalis: A Comprehensive Review
Biological Diversity, EarlyView.ABSTRACT Recent growth in phytotherapy and product‐based drug development has increased interest in this plant because of its broad pharmacological activity. This review aims to examine the pharmacological activities, mechanisms, and potential applications of Borago officinalis, focusing on its primary bioactive constituents and therapeutic ...
Zahra Sufwan +2 more
wiley +1 more source
Hepatology, EarlyView., 2022 Graphical abstract summarizing the study design, main results and key findings Abstract Background and Aims Fatty liver disease (FLD) has been associated with excess mortality. Screening for hepatic steatosis (HS) in patients with metabolic dysfunction is therefore recommended by several guidelines, despite a paucity of evidence on the clinical ...
Laurens A. van Kleef +5 more
wiley +1 more source
Cutaneous reactions due to antihypertensive drugs
Indian Journal of Dermatology, 2006 Out of a total of 1147 patients on antihypertensive drugs, 23 (2.04%) developed adverse cutaneous drug reactions (ACDR). The commonest antihypertensive drug group causing ACDR was beta-blockers of which atenolol was the commonest culprit.
Upadhayai J +5 more
doaj
Journal of Multidisciplinary Healthcare, 2021 Nur Azizah,1,2 Eli Halimah,1,3 Irma Melyani Puspitasari,1,3 Aliya Nur Hasanah4 1Department of Pharmacology and Clinical Pharmacy, Faculty of Pharmacy, Universitas Padjadjaran, Sumedang, West Java, 45363, Indonesia; 2Muhammadiyah Kuningan Institute of ...
Azizah N +3 more
doaj
Pharmaciana, 2012 Drug interactions are one of the Drug Related Problems (DRPs) that may affect patient treatment outcomes. Hypertension occurs in approximately 10% to 81.5% of hemodialysis patients.
Siti Rahmiati, Woro Supadmi
doaj +1 more source
Preservation therapy for vertically fractured teeth with periodontal tissue regeneration using FGF‐2
Clinical Advances in Periodontics, EarlyView.Abstract Background Vertically fractured teeth often have a poor prognosis, and extraction is considered the most predictable treatment. Conventional management has consisted of preservation therapy involving extraction, bonding, root restoration, and replantation of fractured teeth.
Masaichiro Iwasaki +4 more
wiley +1 more source